US Stock MarketDetailed Quotes

GLMD Galmed Pharmaceuticals

Watchlist
  • 3.0500
  • -0.0200-0.65%
Close Dec 20 16:00 ET
  • 3.0500
  • 0.00000.00%
Post 20:01 ET
4.60MMarket Cap-0.73P/E (TTM)

About Galmed Pharmaceuticals Company

Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.

Company Profile

SymbolGLMD
Company NameGalmed Pharmaceuticals
Listing DateMar 13, 2014
Issue Price13.50
Founded2000
CEOMr. Allen Baharaff
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address16 Abba Hillel Road
CityRamat Gan
ProvinceTel Aviv
CountryIsrael
Zip Code5250608
Phone972-3-693-8448
Websitehttp://galmedpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Allen Baharaff
  • Director, President and Chief Executive Officer
  • 1.36M
  • Dr. Liat Hayardeny
  • Chief Scientist Officer
  • 239.89K
  • Yohai Stenzler
  • Chief Accounting Officer
  • 354.14K
  • Guy Nehemya
  • Chief Operating Officer and Data Protection Officer
  • 350.21K
  • Doron Cohen
  • Chief Financial Officer
  • 159.66K
  • Shmuel Nir
  • Independent Director
  • --
  • Dr. David Sidransky, M.D.
  • Lead Independent Director
  • --
  • Dr. Carol L. Brosgart, M.D.
  • Independent Director
  • --
  • Amir Poshinski
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data